Similar Articles

Browse Main Topics:

Business
Computers & Electronics
Education & Reference
Entertainment & Leisure
Family & Home
Finance & Investment
Health
Internet
Pets & Animals
Science & Technology
Society, Politics & Culture
Sports & Recreation

Similar Articles

Wired July 24, 2007 Thomas Goetz	The Ultimate Diagnostic Device (By the Way, You've Got Drug-Resistant TB!) The CDC's goal of a tuberculosis-free society grew short due to the development of drug-resistant strains. But new standards for detection are in the works.
Bio-IT World Jul/Aug 2006 Robert M. Frederickson	Tests for Hospital-Acquired Infections Tests for pathogens increasingly rely on genomic methods that identify specific genetic signatures of bacteria or viruses. Rapid detection of other pathogens also provides the potential for significant impact on the healthcare industry.
Bio-IT World October 14, 2004 Robert M. Frederickson	Nanosphere Strikes Gold Recently, scientists at Nanosphere developed a colorimetric method for DNA detection that obviates the need for target or signal amplification.
Chemistry World July 2010 Anna Lewcock	Medicine made to measure Healthcare tailored to suit the genetic makeup of the patient is finally coming to fruition.
Food Engineering May 1, 2005 Kevin T. Higgins	A better germ-detecting mousetrap A quick test designed for combat soldiers under attack from biological weapons could make life easier for food companies concerned about pathogens in their plants and products.
Reactive Reports David Bradley	Integrated Biochips A new microfluidic device that can perform sample preparation, polymerase chain reaction, and microarray detection functions on a single device has been developed by US researchers.
Industrial Physicist Aug/Sep 2003 Jennifer Ouellette	A new wave of microfluidic devices Flexibility and a variety of uses are the key
Chemistry World February 11, 2011 Elinor Richards	Thirty minute flu gene detector Scientists in Japan have developed a portable influenza testing kit with better accuracy than current methods, which can give a result in 30 minutes.
IEEE Spectrum March 2006 Barry E. DiGregorio	A Better Anthrax Screener? A newly marketed anthrax detector that originated in the U.S. space program promises to halve the detection time of the system currently used by the U.S. Postal Service.
Salon.com May 1, 2000 Arthur Allen	Listening to DNA The genome project is getting the buzz. But the real breakthroughs may come from labs out of the limelight, like Gene Logic.
BusinessWeek September 5, 2005 Capell & Arndt	Drugs Get Smart Future medicines will more effectively target what ails you by tailoring treatment to your specific genetic profile. Personalized medicine will also help prevent another Vioxx.
National Defense July 2004 Joe Pappalardo	Scientists Seek Breakthroughs In Bio-Detection The Department of Homeland Security is seeking to upgrade its biological sensor network with more encompassing and less costly systems.
Bio-IT World November 14, 2003 Jason B. Lee	Profiting from the BioShield How can software developers ensure a share of the tremendous biodefense funding available to bio-IT companies -- and what are the risks?
Bio-IT World February 18, 2004	Pathology Goes Molecular New technologies are enabling clinical diagnostic laboratories to pave the way toward more personalized cancer therapies
Chemistry World August 19, 2009 Hayley Birch	Gold nanoparticles detect cancer Chinese scientists have used gold nanoparticles as ultrasensitive fluorescent probes to detect cancer biomarkers in human blood.
Chemistry World April 2, 2015 Jenny Lovell	DNA test colors in BRCA1 gene Researchers in China have developed an ultrasensitive test that changes color when it detects a gene associated with an increased risk of developing breast and ovarian cancer.
Chemistry World June 13, 2012 Elinor Hughes	Paper and plastic HIV test A DNA test to detect HIV in infants in resource-poor countries is a step closer, thanks to a technique to amplify DNA samples developed by US scientists.
Technology Research News December 3, 2003 Eric Smalley	Biochip puts it all together Researchers have made all manner of microfluidic machines, but have yet to come up with cheap, mass-producible biochips for handheld medical and environmental testing. A simple plastic chip puts the necessary pieces together. The $7 device tests blood samples for the presence of E. coli bacteria.
Technology Research News August 25, 2004	DNA Copier Uses Little Power Today's laboratory DNA detectors require a lot of energy. Researchers have devised a method that copies the way DNA is replicated biologically in order to avoid the energy-intensive heating and cooling process.
National Defense June 2007 Breanne Wagner	Government Contracts Focus on Vaccines, Emergency Response Since October 2006, 13 contracts have been awarded to industry and academia, ranging in value from $2.7 million to $28 million.
Wired August 2003 Jennifer Kahn	The End of Cancer (As we Know it) Diagnosis. Chemotherapy. Radiation. Slow painful death. No more. A new era of cancer treatment is dawning. Meet three scientists who are using the revelations of the Human Genome Project to reshape medicine.
Chemistry World April 1, 2011 Erica Wise	DNA detection for rapid HIV diagnosis The diagnosis of HIV in developing countries could be quicker using a low cost device developed by US scientists.
Chemistry World June 3, 2015 Rebecca Trager	Biosafety blunder as US sends live anthrax to labs around world Revelations that the US Department of Defense accidentally shipped live anthrax samples to at least 24 labs in 11 states and two foreign countries has prompted a congressional committee to demand answers.
Bio-IT World September 9, 2002 Malorye Branca	The New, New Pharmacogenomics The field of pharmacogenomics proves valuable in the battle against toxicity and late-stage drug failure -- one of the pharmaceutical industry's biggest problems.
Fast Company November 2009 David H. Freedman	The Gene Bubble: Why We Still Aren't Disease-Free When the human genome was first sequenced nearly a decade ago, the world lit up with talk about how new gene-specific drugs would help us cheat death. Well, the verdict is in: Keep eating those greens.
Chemistry World June 20, 2013 Sarah Houlton	US supreme court rules genes can't be patented In a long-running case against Myriad Genetics, the court decided the BRCA1 and BRCA2 genes are a 'product of nature, and not patent eligible merely because [they have] been isolated.'
Chemistry World September 8, 2014 Emma Stoye	CPU heat powers PCR disease detection Scientists in the US have devised a new way of carrying out blood tests -- based on a modified computer and camera phone -- that could lower the costs of disease screening in developing countries.
HHMI Bulletin May 2012 Sarah C. P. Williams	Stephen Quake: Innovative Thinking on Genetic Tests His ideas have already led to a blood test to tell a pregnant woman whether her fetus has Down syndrome. Now, the HHMI investigator is pushing further, to track the success of heart transplants and diagnose autoimmune diseases and allergies.
Bio-IT World September 2006 Robert M. Frederickson	Assays and Knowledgebases for Genomic Analysis An important aspect of any genomic analysis -- whether expression profiling or analysis of DNA-binding elements as above -- is the integration of the data with existing knowledge.
The Motley Fool February 2, 2010 Brian Orelli	Shaking Up the Biotech Industry A judge will decide if genes are patentable or not.
Chemistry World April 21, 2011 David Barden	RNA analysis raises hopes of early cancer diagnosis An improved method for diagnosing colorectal cancer without using invasive techniques has been developed by scientists in China.
IEEE Spectrum April 2005 Prachi Patel Predd	Riding Life's Twists and Turns How a strand of DNA launched the co-founder of Nanogen's career in the technology behind DNA microarrays.
Chemistry World September 4, 2015 Matthew Gunther	US regulator reprimands Cepheid for norovirus diagnosis tool quality The US Food and Drug Administration has admonished the molecular diagnostics company Cepheid for failing to maintain good manufacturing practices.
The Motley Fool March 31, 2010 Brian Orelli	When One Patent Means So Much The loss of patents on genes could have far-reaching consequences for drug companies.
National Defense November 2014 Stew Magnuson	New Approach to Biological Threat Detection Promises Savings for Defense, Homeland Security The nonprofit lab Battelle recently introduced an all-inclusive chemical-biological-explosive detector the size of a microwave oven that can detect airborne pathogens in minutes with recurring costs of about $1 per day.
Salon.com April 24, 2000 Mark Compton	Lean, green gene-counting machine Incyte CEO Roy Whitfield gives biotech investors and patent critics a few lessons on genomic research.
Chemistry World April 10, 2015 Matthew Gunther	Silicon chip spots dangerous pathogens in human blood Scientists in China have developed a silicon chip doped with silver nanoparticles that can rapidly detect different pathogens in blood samples.
Technology Research News July 30, 2003 Eric Smalley	Chip senses trace DNA Handheld detectors could one day allow you to monitor your body for cancer, your water for chemicals, and your food for bacteria. This requires inexpensive electronics that are capable of detecting trace amounts of substances. One candidate is a chip containing DNA-tipped carbon nanotubes.
Bio-IT World April 15, 2003 Malorye Branca	Beyond the Blueprint How will the wealth of data emanating from the human genome and allied technologies impact research on health and disease?
Bio-IT World November 2005 Khaleeli & Fernandez	Patent Prosecution and Enforcement in Pharmacogenomics Patenting the composition of an isolated nucleic acid sequence, an isolated protein, and small molecules is possible, but there are challenges claiming that they resulted from pharmacogenomic research.
Bio-IT World October 9, 2002 Malorye Branca	The Path to Personalized Medicine The tactics have changed, sometimes dramatically, but hints of the promise of pharmacogenomics are finally starting to trickle in from studies of asthma, cancer, and drug response.
Chemistry World December 3, 2010 Yuandi Li	Microfluidics to fight cholera A cheap and portable device to detect cholera has been made by Italian researchers that could help significantly reduce the number of cholera related deaths.
Wired November 2002 David Ewing Duncan	DNA as Destiny DNA is the book of life. It's also the book of death. In the future we'll all be read cover to cover. Here's what it's like to take the world's first top-to-bottom gene scan.
National Defense March 2014 Stew Magnuson	Company Creates BioWatch 'Lab in a Box' After six years of development, a technology firm says it has created what has been a holy grail for the Department of Homeland Security's BioWatch program: a laboratory in a box.
Chemistry World January 20, 2011 James Urquhart	SNPs on display DNA origami and atomic force microscopy have been combined to reliably detect and image single nucleotide polymorphisms, the most common form of genetic variation in the human genome.
Bio-IT World August 13, 2003 Kevin Davies	Playing by Aussie Rules GTG's Mervyn Jacobson discusses the controversial patenting of non-coding DNA.
Managed Care August 2004 Thomas Morrow	10,000 Cells on a Chip Signal Start of New Era of Diagnosis Diseases will soon be defined by biochemical pathways and genetic interactions. Biochips may identify patients likely to respond to therapeutic agents. All of this is a big deal for health plans.
Chemistry World January 7, 2015 Rebecca Trager	Myriad loses appeal on cancer gene test patents Myriad Genetics has lost its appeal over patents on the BRCA genes that are associated with a higher risk of breast and ovarian cancer.
Chemistry World March 19, 2007 Jessica Ebert	Pocket-Sized PCR Machine Scientists in the US report being one step closer to designing a miniaturized, portable polymerase chain reaction machine that could be used for applications such as point-of-care diagnostics.
The Motley Fool September 26, 2006 Ralph Casale	Biotech's Distant Star Cepheid still isn't a profitable company, but strong sales growth should continue. This is a high risk holding until it demonstrates profitability and its instruments are widely adopted.